Analyst Ratings for TherapeuticsMD (TXMD)

TXMD Rating Summary

  |   Expand Research on TXMD
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 6.7 / 10   Percentile Rank: 71%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/10/2023 Cantor Fitzgerald Louise Chen New Coverage Neutral
(N/A)		 5.00
(N/A)		 5.33
(1.88)		 -64.73% Details
6/7/2022 H.C. Wainwright N/A Downgrade Neutral
(Buy)		 N/A
(N/A)		 9.97
(1.88)		 -81.14% Details